Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/56433
TRYPANOSOMA CRUZI PATHOGENICITY INVOLVES VIRULENCE FACTOR EXPRESSION AND UPREGULATION OF BIOENERGETIC AND BIOSYNTHETIC PATHWAYS
Author
Francisco, Juan San
Astudillo, Constanza
Vega, José Luis
Catalán, Alejandro
Gutiérrez, Bessy
Araya, Jorge E
Zailberger, Anibal
Marina, Anabel
García, Carlos
Sanchez, Nuria
Osuna, Antonio
Vilchez, Susana
Ramirez, Marcel Ivan
Macedo, Janaina
Feijoli, Verónica Santiago
Palmisano, Giuseppe
González, Jorge
Astudillo, Constanza
Vega, José Luis
Catalán, Alejandro
Gutiérrez, Bessy
Araya, Jorge E
Zailberger, Anibal
Marina, Anabel
García, Carlos
Sanchez, Nuria
Osuna, Antonio
Vilchez, Susana
Ramirez, Marcel Ivan
Macedo, Janaina
Feijoli, Verónica Santiago
Palmisano, Giuseppe
González, Jorge
Affilliation
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Laboratory of gap junction proteins and parasitic disease. Antofagasta Institut, University of Antofagasta, Antofagasta, Chile. / Research Center in Immunology and Biomedical Biotechnology of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
National University of La Plata. La Plata, Argentina.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Institute of Biotechnology. University of Granada, Granada, Spain.
Institute of Biotechnology. University of Granada, Granada, Spain.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Molecular e Sistêmica de Tripanossomatídeos. Curitiba, PR, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile. / Research Center in Immunology and Biomedical Biotechnology of Antofagasta. Antofagasta, Chile. / Laboratório de Biologia Molecular e Sistemática de Trypanosomatides. Millennium Institute on Immunology and Immunotherapy. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Laboratory of gap junction proteins and parasitic disease. Antofagasta Institut, University of Antofagasta, Antofagasta, Chile. / Research Center in Immunology and Biomedical Biotechnology of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile.
National University of La Plata. La Plata, Argentina.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Universidad Autonoma de Madrid. Centro de Biología Molecular Severo Ochoa. Madrid, Spain.
Institute of Biotechnology. University of Granada, Granada, Spain.
Institute of Biotechnology. University of Granada, Granada, Spain.
Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Molecular e Sistêmica de Tripanossomatídeos. Curitiba, PR, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Universidade de São Paulo. Departamento de Parasitologia. São Paulo, SP, Brasil.
Molecular Parasitology Unit. Medical Technology Department. University of Antofagasta. Antofagasta, Chile. / Research Center in Immunology and Biomedical Biotechnology of Antofagasta. Antofagasta, Chile. / Laboratório de Biologia Molecular e Sistemática de Trypanosomatides. Millennium Institute on Immunology and Immunotherapy. Antofagasta, Chile.
Abstract
The molecular repertoire of Trypanosoma cruzi effects its virulence and impacts the clinical course of the resulting Chagas disease. This study aimed to determine the mechanism underlying the pathogenicity of T. cruzi. Two T. cruzi cell lines (C8C3hvir and C8C3lvir), obtained from the clone H510 C8C3 and exhibiting different virulence phenotypes, were used to evaluate the parasite’s infectivity in mice. The organ parasite load was analysed by qPCR. The proteomes of both T. cruzi cell lines were compared using nLC- S/MS. Cruzipain (Czp), complement regulatory protein (CRP), trans-sialidase (TS), Tc-85, and sialylated epitope expression levels were evaluated by immunoblotting. High-virulence C8C3hvir was highly infectious in mice and demonstrated three to five times higher infectivity in mouse myocardial cells than low-virulence C8C3lvir. qPCR revealed higher parasite loads in organs of acute as well as chronically C8C3hvir-infected mice than in those of C8C3lvir-infected mice. Comparative quantitative proteomics revealed that 390 of 1547 identified proteins were differentially regulated in C8C3hvir with respect to C8C3lvir. Amongst these, 174 proteins were upregulated in C8C3hvir and 216 were downregulated in C8C3lvir. The upregulated proteins in C8C3hvir were associated with the tricarboxylic acid cycle, ribosomal proteins, and redoxins. Higher levels of Czp, CRP, TS, Tc-85, and sialylated epitopes were expressed in C8C3hvir than in C8C3lvir. Thus, T. cruzi virulence may be related to virulence factor expression as well as upregulation of bioenergetic and biosynthetic pathways proteins.
Share